WikiTrademarks - Search, analyse, and monitor trademark applications.

Trademark: BENDEKA (BENDAMUSTINE HCI) INJECTION

Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io

Tweet this

Track updates on BENDEKA (BENDAMUSTINE HCI) INJECTION

Mark Identification

Proof of use for BENDEKA (BENDAMUSTINE HCI) INJECTION

We do not have any records of a proof of use for BENDEKA (BENDAMUSTINE HCI) INJECTION at this moment.

Click here to add a proof of use for BENDEKA (BENDAMUSTINE HCI) INJECTION

Possible trademark infringements of BENDEKA (BENDAMUSTINE HCI) INJECTION

Basic Information about BENDEKA (BENDAMUSTINE HCI) INJECTION

Serial Number
86826918
Filing Date
20 Nov 2015
Registration Number
5014705
Registration Date
02 Aug 2016
Mark Drawing Code
3

Classifications

Declare the trademark use of BENDEKA (BENDAMUSTINE HCI) INJECTION on the blockchain with WikiTrademarks.io.

First use of BENDEKA (BENDAMUSTINE HCI) INJECTION anywhere
BENDEKA (BENDAMUSTINE HCI) INJECTION was first used on 27 Apr 2016 for the primary classification of goods and services, international, 044 (Medical, beauty & agricultural)
First use in commerce
There is no first use of this trademark in commerce detected yet.
Status Code
6
International Code
044
US Codes
100; 101

Who owns BENDEKA (BENDAMUSTINE HCI) INJECTION?

2. Cephalon, Inc. Frazer PA

3. Cephalon, Inc. Frazer PA

4. Cephalon, Inc. Frazer PA

Correspondent

Laurence Rickles
TEVA PHARMACEUTICALS USA, INC.
400 Interpace Parkway, Building A
Parsippany NJ 07054

Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io

Tweet this

Track updates on BENDEKA (BENDAMUSTINE HCI) INJECTION